ANDS Insider Trading Activity and SEC Form 4 Filings
ANDS insider trading summary
No open-market insider purchases or sales of Anadys Pharmaceuticals Inc (ANDS) have been reported on SEC Form 4 in the past 12 months.
Latest ANDS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 21, 2011 | QVT Associates GP LLC | 10% Owner | Sell | $1.3M (364,918 @ $3.68) |
| Oct 21, 2011 | QVT Fund LP | 10% Owner | Sell | $1.3M (364,918 @ $3.68) |
| Oct 20, 2011 | QVT Associates GP LLC | 10% Owner | Sell | $19.3M (5,252,700 @ $3.68) |
| Oct 20, 2011 | QVT Fund LP | 10% Owner | Sell | $19.3M (5,252,700 @ $3.68) |
| Oct 17, 2011 | QVT Fund LP | 10% Owner | Sell | $2.4M (650,100 @ $3.68) |
| Oct 17, 2011 | QVT Associates GP LLC | 10% Owner | Sell | $2.4M (650,100 @ $3.68) |
| Jan 3, 2011 | QVT Associates GP LLC | 10% Owner | Buy | $48K (34,209 @ $1.41) |
| Jan 3, 2011 | QVT Fund LP | 10% Owner | Buy | $48K (34,209 @ $1.41) |
| Dec 30, 2010 | QVT Fund LP | 10% Owner | Buy | $444 (300 @ $1.48) |
| Dec 30, 2010 | QVT Associates GP LLC | 10% Owner | Buy | $444 (300 @ $1.48) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.